These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticomplementary activity of boswellic acids--an inhibitor of C3-convertase of the classical complement pathway. Kapil A, Moza N. Int J Immunopharmacol; 1992 Oct; 14(7):1139-43. PubMed ID: 1452399 [Abstract] [Full Text] [Related]
5. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Sahu A, Rawal N, Pangburn MK. Biochem Pharmacol; 1999 Jun 15; 57(12):1439-46. PubMed ID: 10353266 [Abstract] [Full Text] [Related]
6. FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a. Inagi R, Miyata T, Maeda K, Sugiyama S, Miyama A, Nakashima I. Immunol Lett; 1991 Jan 15; 27(1):49-52. PubMed ID: 2019419 [Abstract] [Full Text] [Related]
8. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella. Phipps D, Menger M, Chadwick JS, Aston WP. Dev Comp Immunol; 1987 Jan 15; 11(1):37-46. PubMed ID: 3647909 [Abstract] [Full Text] [Related]
12. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate. Asghar SS, de Koster A, van der Helm HJ. Biochem Pharmacol; 1986 Sep 01; 35(17):2917-21. PubMed ID: 3638137 [Abstract] [Full Text] [Related]
13. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase. Fu Q, McPhie P, Gowda DC. Biochem Mol Biol Int; 1998 Jun 01; 45(1):133-44. PubMed ID: 9635137 [Abstract] [Full Text] [Related]
14. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. Medof ME, Kinoshita T, Nussenzweig V. J Exp Med; 1984 Nov 01; 160(5):1558-78. PubMed ID: 6238120 [Abstract] [Full Text] [Related]
15. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement. Smith CA, Vogel CW, Müller-Eberhard HJ. J Biol Chem; 1982 Sep 10; 257(17):9879-82. PubMed ID: 6921201 [Abstract] [Full Text] [Related]
16. Recombinant cobra venom factor. Vogel CW, Fritzinger DC, Hew BE, Thorne M, Bammert H. Mol Immunol; 2004 Jun 10; 41(2-3):191-9. PubMed ID: 15159065 [Abstract] [Full Text] [Related]
17. Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system. Van den Berg CW, Aerts PC, Van Dijk H. J Immunol Methods; 1990 Oct 19; 133(2):199-206. PubMed ID: 2230138 [Abstract] [Full Text] [Related]
18. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. Vogel CW, Müller-Eberhard HJ. J Biol Chem; 1982 Jul 25; 257(14):8292-9. PubMed ID: 6919543 [No Abstract] [Full Text] [Related]
19. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro. Brown EJ, Joiner KA, Frank MM. J Clin Invest; 1983 Jun 25; 71(6):1710-9. PubMed ID: 6863540 [Abstract] [Full Text] [Related]